Effect of trifluridine/tipiracil in patients treated in RECOURSE by prognostic factors at baseline: an exploratory analysis.

Josep Tabernero Guillem ArgilésAlberto F SobreroChristophe BorgAtsushi OhtsuRobert J MayerLoick VidotShanti R Moreno VeraEric Van Cutsem

Published in: ESMO open (2021)

Low tumour burden and indolent disease were factors of good prognosis in late-line mCRC, with patients experiencing longer progression-free survival and greater overall survival.

Keyphrases

prognostic factors
free survival
end stage renal disease
ejection fraction
chronic kidney disease
metastatic colorectal cancer
peritoneal dialysis
risk factors